Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01361204
Other study ID # CT2011001
Secondary ID
Status Completed
Phase N/A
First received May 10, 2011
Last updated July 14, 2013
Start date May 2011
Est. completion date April 2012

Study information

Verified date July 2013
Source University of Shizuoka
Contact n/a
Is FDA regulated No
Health authority Japan: Ministry of Health, Labor and Welfare
Study type Interventional

Clinical Trial Summary

Long-term practices in a hospital setting and community pharmacy might induce chronic stress in students. Alterations of salivary amylase activity will be measured in students during pharmacy practices as a marker of stress. Theanine is reported to have anti-stress effect on experimental animals under chronic stress and on humans under short-term stress. The purpose of this study is to measure stress symptoms in students during long-term pharmacy practices and to evaluate the efficacy of theanine in suppressing chronic stress, by measuring the salivary amylase activity.


Description:

The investigators have found that theanine, an amino acid in green tea, has anti-stress and anti-aging effects using experimental animals. Mice, under chronic psychosocial stress, showed shortened longevity and brain dysfunction. However, when the mice ingested theanine, they showed normal longevity and brain function even though the mice were under psychosocial stress. These data showed that theanine has a significant anti-stress effect on mice. In addition, theanine has been reported to have an anti-stress effect on humans against short-term stress by measuring salivary amylase activity. However, the efficacy of theanine against chronic stress has not been examined. Long-term pharmacy practices might induce chronic stress in students. Based on this background, the investigators designed a randomized study to evaluate the clinical efficacy of theanine ingestion in suppressing chronic stress in students during long-term pharmacy practices.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date April 2012
Est. primary completion date December 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 22 Months to 30 Years
Eligibility Inclusion Criteria:

- Students of pharmaceutical sciences in the fifth grade, nonsmoker

- Obtained written informed consent from the student before participation

- Possible to take tablets for 16 days

- Possible to check salivary amylase activity two times daily for 10 days

Exclusion Criteria:

- Taking tranquilizer(s)

- Smoker

- Diagnosed as inadequate to participate in the study by a doctor

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Theanine
Taking 4 tablets of theanine two times daily for 16 days

Locations

Country Name City State
Japan University of Shizuoka Shizuoka

Sponsors (1)

Lead Sponsor Collaborator
University of Shizuoka

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Alterations in salivary amylase activity in students with pharmacy practices 10 days No
Secondary Numbers of students deteriorated physical condition 10 days No
Secondary Incidence of days of coming late or leaving early 10 days No
Secondary Alterations in sleeping hours from baseline 10 days No
Secondary Alterations in the response to a stress questionnaire from baseline 10 days No
See also
  Status Clinical Trial Phase
Completed NCT04076163 - About the Efficacy of a Serious Game in Critical Appraisal N/A
Completed NCT05873179 - Effects on Emphathy in Physiotherapy Students After Simulation as an Active Method for Learning the Clinical Enterview